Complications of cosmetic eye whitening

Ann Q. Tran, Catherine Hoppener, Nandini Venkateswaran, Daniel S. Choi, Wendy Lee

Research output: Contribution to journalArticle

Abstract

Introduced in 2008 and subsequently popularized in South Korea, cosmetic eye whitening has been offered as a treatment of chronic conjunctival hyperemia. Patients undergo conjunctivectomy with topical mitomycin C (MMC) 0.02% application to achieve a whitened appearance from bleaching of avascular sclera. Much speculation has arisen from this procedure given the limited available evidence on its efficacy and safety. A literature search was performed to review common complications of cosmetic eye whitening, including chronic conjunctival epithelial defects, scleral thinning, avascular zones in the sclera, dry eye syndrome, and diplopia requiring strabismus surgery. Informing the general public of the risks of this procedure is of great importance for dermatologists and other cosmetic surgeons.

Original languageEnglish (US)
Pages (from-to)E24-E26
JournalCutis
Volume100
Issue number3
StatePublished - Sep 1 2017
Externally publishedYes

Fingerprint

Cosmetics
Sclera
Dry Eye Syndromes
Republic of Korea
Diplopia
Strabismus
Hyperemia
Mitomycin
Safety
Therapeutics
Dermatologists
Surgeons

ASJC Scopus subject areas

  • Dermatology

Cite this

Tran, A. Q., Hoppener, C., Venkateswaran, N., Choi, D. S., & Lee, W. (2017). Complications of cosmetic eye whitening. Cutis, 100(3), E24-E26.

Complications of cosmetic eye whitening. / Tran, Ann Q.; Hoppener, Catherine; Venkateswaran, Nandini; Choi, Daniel S.; Lee, Wendy.

In: Cutis, Vol. 100, No. 3, 01.09.2017, p. E24-E26.

Research output: Contribution to journalArticle

Tran, AQ, Hoppener, C, Venkateswaran, N, Choi, DS & Lee, W 2017, 'Complications of cosmetic eye whitening', Cutis, vol. 100, no. 3, pp. E24-E26.
Tran AQ, Hoppener C, Venkateswaran N, Choi DS, Lee W. Complications of cosmetic eye whitening. Cutis. 2017 Sep 1;100(3):E24-E26.
Tran, Ann Q. ; Hoppener, Catherine ; Venkateswaran, Nandini ; Choi, Daniel S. ; Lee, Wendy. / Complications of cosmetic eye whitening. In: Cutis. 2017 ; Vol. 100, No. 3. pp. E24-E26.
@article{6ca3eada0367458ea25bd72fbb93c5b5,
title = "Complications of cosmetic eye whitening",
abstract = "Introduced in 2008 and subsequently popularized in South Korea, cosmetic eye whitening has been offered as a treatment of chronic conjunctival hyperemia. Patients undergo conjunctivectomy with topical mitomycin C (MMC) 0.02{\%} application to achieve a whitened appearance from bleaching of avascular sclera. Much speculation has arisen from this procedure given the limited available evidence on its efficacy and safety. A literature search was performed to review common complications of cosmetic eye whitening, including chronic conjunctival epithelial defects, scleral thinning, avascular zones in the sclera, dry eye syndrome, and diplopia requiring strabismus surgery. Informing the general public of the risks of this procedure is of great importance for dermatologists and other cosmetic surgeons.",
author = "Tran, {Ann Q.} and Catherine Hoppener and Nandini Venkateswaran and Choi, {Daniel S.} and Wendy Lee",
year = "2017",
month = "9",
day = "1",
language = "English (US)",
volume = "100",
pages = "E24--E26",
journal = "Cutis",
issn = "0011-4162",
publisher = "Quadrant Healthcom Inc.",
number = "3",

}

TY - JOUR

T1 - Complications of cosmetic eye whitening

AU - Tran, Ann Q.

AU - Hoppener, Catherine

AU - Venkateswaran, Nandini

AU - Choi, Daniel S.

AU - Lee, Wendy

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Introduced in 2008 and subsequently popularized in South Korea, cosmetic eye whitening has been offered as a treatment of chronic conjunctival hyperemia. Patients undergo conjunctivectomy with topical mitomycin C (MMC) 0.02% application to achieve a whitened appearance from bleaching of avascular sclera. Much speculation has arisen from this procedure given the limited available evidence on its efficacy and safety. A literature search was performed to review common complications of cosmetic eye whitening, including chronic conjunctival epithelial defects, scleral thinning, avascular zones in the sclera, dry eye syndrome, and diplopia requiring strabismus surgery. Informing the general public of the risks of this procedure is of great importance for dermatologists and other cosmetic surgeons.

AB - Introduced in 2008 and subsequently popularized in South Korea, cosmetic eye whitening has been offered as a treatment of chronic conjunctival hyperemia. Patients undergo conjunctivectomy with topical mitomycin C (MMC) 0.02% application to achieve a whitened appearance from bleaching of avascular sclera. Much speculation has arisen from this procedure given the limited available evidence on its efficacy and safety. A literature search was performed to review common complications of cosmetic eye whitening, including chronic conjunctival epithelial defects, scleral thinning, avascular zones in the sclera, dry eye syndrome, and diplopia requiring strabismus surgery. Informing the general public of the risks of this procedure is of great importance for dermatologists and other cosmetic surgeons.

UR - http://www.scopus.com/inward/record.url?scp=85041397505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041397505&partnerID=8YFLogxK

M3 - Article

VL - 100

SP - E24-E26

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 3

ER -